Complete Video Program

Each presentation is designated by the Society for Translational Oncology for .5 AMA PRA Category 1 Credit™ except for those marked with * to indicate the presenters' industry affiliations.
 

April 21, 2021

Moderator

Aditya Bardia, MD, MPH
Massachusetts General Hospital Cancer Center, Harvard Medical School

 

Pancancer Analysis of Whole Genomes
Gad Getz, PhD
Broad Institute/MGH Cancer Center
CME

Kinase Pathway Targeted Therapeutics
Keith T. Flaherty, MD
MGH Cancer Center/Harvard Medical School
CME


April 28, 2021

Moderator

Jochen Lennerz, MD
Center for Integrated Diagnostics, Massachusetts General Hospital

 

Genotyping Techniques and Reports*
Geoff R. Oxnard, MD
Foundation Medicine

Germline and Ethical Considerations
Leif W. Ellisen, MD, PhD
MGH Cancer Center/Harvard Medical School
CME


May 5, 2021

Moderator

Aparna Parikh, MD, MS
Termeer Center for Targeted Therapies, Massachusetts General Hospital Cancer Center

 

Targeting PI3K Pathway
Dejan Juric, MD
MGH/Termeer Center for Targeted Therapies
CME
Plasma vs Tissue Genotyping: Debate
(Pro Tissue – Dr. Iafrate; Pro Plasma – Dr. Corcoran)

A. John Iafrate, MD
MGH/Harvard Medical School
Ryan B. Corcoran, MD, PhD
MGH Cancer Center/Harvard Medical School
CME


May 12, 2021

Moderator

Aaron Hata, MD, PhD
Massachusetts General Hospital

 

Targeting ALK, ROS and Other Fusion Drivers*
Alice T. Shaw, MD, PhD
Novartis
 
Targeting MET
Rebecca S. Heist, MD, MPH
MGH/Harvard Medical School
CME


May 19, 2021

Moderator

Ryan J. Sullivan, MD
Massachusetts General Hospital Cancer Center

 

Role of Immunotherapy in the Era of Precision Medicine
Justin F. Gainor, MD
MGH Cancer Center/Harvard Medical School
CME
Role of Antibody Drug Conjugates in the Era of Precision Medicine
David R. Spriggs, MD
MGH Cancer Center/Harvard Medical School
CME